Evidence map›Paper›PMID 42862836›Full record

ArticlePLoS pathogens2026

Toxin-mediated tRNATrp depletion drives Trp-codon-dependent reprogramming in Mycobacterium tuberculosis while selectively enriching the PDIM biosynthetic machinery.

Safreen Sain, Unnati Chauhan, Valdir C Barth, Eduardo A Troian, Bruno L Abbadi, Basanti Malakar, Robert N Husson, Nancy A Woychik

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Safreen SainDepartment of Biochemistry and Molecular Biology, Rutgers Health, Robert Wood Johnson Medical School, Piscataway, New Jersey, United States of America.
Unnati ChauhanDepartment of Biochemistry and Molecular Biology, Rutgers Health, Robert Wood Johnson Medical School, Piscataway, New Jersey, United States of America.
Valdir C BarthDivision of Infecti ous Diseases, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Eduardo A TroianDepartment of Biochemistry and Molecular Biology, Rutgers Health, Robert Wood Johnson Medical School, Piscataway, New Jersey, United States of America.ORCID https://orcid.org/0000-0002-8957-2691
Bruno L AbbadiDepartment of Biochemistry and Molecular Biology, Rutgers Health, Robert Wood Johnson Medical School, Piscataway, New Jersey, United States of America.
Basanti MalakarDivision of Infecti ous Diseases, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Robert N HussonDivision of Infecti ous Diseases, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Nancy A WoychikDepartment of Biochemistry and Molecular Biology, Rutgers Health, Robert Wood Johnson Medical School, Piscataway, New Jersey, United States of America.ORCID https://orcid.org/0000-0002-3996-2990

Funding

Genome exploration through toxin-mediated ribosome stallingR01AI154464 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI WOYCHIK, NANCY ANN · 2020 to 2023
$1.5M
An Orbitrap Tribrid mass spectrometer and nanoflow LC system to upgrade the proteomics facility at Rutgers-New Brunswick and Robert Wood Johnson Medical SchoolS10OD025140 · OD · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI LOBEL, PETER · 2019 to 2019
$921k
NIAID NIH HHS R01 AI154464NIH HHS S10 OD025140
6 · The paper itself

Abstract

Mycobacterium tuberculosis (Mtb) must adapt to host-imposed stresses that limit its growth and ability to establish an infection. One important immune-regulated host defense mechanism involves competition between host and pathogen for tryptophan (Trp). Although Mtb is a Trp prototroph capable of synthesizing its own Trp, it normally acquires this amino acid from host macrophages because of the high energetic cost of its synthesis. However, interferon-γ-activated macrophages attempt to restrict Mtb growth by inducing indoleamine 2,3-dioxygenase 1 (IDO1) that degrades Trp. In response, Mtb senses and adapts to limitation of this essential amino acid by inducing its own Trp biosynthetic pathway, although the mechanisms coupling Trp limitation and compensatory Trp biosynthesis remain unknown. Here, we studied the Mtb VapC37 toxin and demonstrate that it arrests growth and is a highly selective tRNase that exclusively depletes tRNATrp. Consequently, VapC37 triggers a state of perceived Trp starvation to upregulate production of Trp biosynthetic enzymes. Therefore, this toxin appears to link intracellular Trp availability-a well-established regulator of Mtb growth-to a codon-dependent adaptive response to increase the Trp concentration. VapC37 also broadly reprograms the Mtb transcriptome and translatome toward synthesis of mRNAs and proteins with low or no Trp codons. However, there is one striking exception: key enzymes in the phthiocerol dimycocerosate (PDIM) biosynthetic pathway were robustly synthesized despite being large and Trp-numerous, resulting in a > 2-fold increase in PDIM lipid production upon VapC37 expression. Thus, Mtb selectively preserves PDIM production under conditions of tRNATrp limitation. Finally, VapBC37 and PDIM transcripts are upregulated in Mtb cells subjected to nitrosative stress and upon Mtb infection of THP-1 macrophage-like cells. This might implicate early macrophage-associated stresses as activators of VapC37, possibly enabling this toxin to reallocate metabolic priorities toward Trp biosynthesis while selectively preserving PDIM production critical for Mtb early immune escape and virulence.

Indexed as

Bacterial ToxinsMycobacterium tuberculosisTryptophanTuberculosisBacterial ProteinsHumansMacrophagesBacterial ProteinsBacterial ToxinsTryptophan

Identifiers

PMID42862836
PMCPMC13657306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.